1. Denosumab Reduces the Incidence of New Vertebral Fractures in Men With Prostate Cancer

   • David S. Silver

   CLINICAL TRIAL REPORT Open access 19 February 2010 Pages: 1 - 3

2. Intravenous Zoledronic Acid: What Are the Indications for Male Osteoporosis?

   • Michael Maricic

   ReviewPaper 11 March 2010 Pages: 4 - 9

3. Glucocorticoid-Induced Osteoporosis: Management Update

   • Robert A. Adler

   ReviewPaper 20 February 2010 Pages: 10 - 14

4. Benefits and Limitations of Bone Mineral Density and Bone Turnover Markers to Monitor Patients Treated for Osteoporosis

   • E. Michael Lewiecki

   ReviewPaper 20 February 2010 Pages: 15 - 22

5. Anabolic Therapies

   • Nancy E. Lane
   • Stuart L. Silverman

   ReviewPaper Open access 19 February 2010 Pages: 23 - 27

6. Orthopedic Uses of Teriparatide

   • Susan V. Bukata
   • J. Edward Puzas

   ReviewPaper 03 March 2010 Pages: 28 - 33

7. Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates

   • Jeri W. Nieves
   • Felicia Cosman

   ReviewPaper 02 March 2010 Pages: 34 - 39

8. The Role of Microbial Biofilms in Osteonecrosis of the Jaw Associated with Bisphosphonate Therapy

   • Satish K. S. Kumar
   • Amita Gorur
   • Parish P. Sedghizadeh

   ReviewPaper 19 February 2010 Pages: 40 - 48

   

9. Is Osteoporosis Disease Management Cost Effective?

   • Richard Dell
   • Denise Greene

   ReviewPaper 20 February 2010 Pages: 49 - 55